Italian guidelines for the diagnosis and treatment of patients with haemophilia and inhibitors
- 12 October 2005
- journal article
- guideline
- Published by Wiley in Haemophilia
- Vol. 11 (6), 611-619
- https://doi.org/10.1111/j.1365-2516.2005.01161.x
Abstract
The Italian Association of Haemophilia Centres reviewed and finally approved in November 2004 the new Italian Guidelines for the diagnosis and treatment of patients with clotting factor inhibitors. The recommendations have been based on the identification of levels of clinical evidence derived from the systematic review carried out in 2003 by the School of Health and Related Research, the University of Sheffield, UK, and further integrated by clinical studies published from 2003 to 2004. The Italian guidelines consist of six major domains concerning inhibitor definition, epidemiology, risk factors, diagnosis, inhibitor eradication, management of bleeding episodes, in patients with congenital and acquired coagulation disorders, with 121 statements, 59 synthesis and 54 recommendations. We report here recommendations and open issues concerning the diagnosis and monitoring of inhibitors, inhibitor eradication and the management of bleeding in patients with haemophilia A and B.Keywords
This publication has 93 references indexed in Scilit:
- Selective B-cell depletion with rituximab for the treatment of patients with acquired hemophiliaBlood, 2004
- Extracorporeal adsorption of anti-Factor VIII allo-antibodies on randomly functionalized polystyrene resinsThrombosis and Haemostasis, 2004
- Inhibitor Antibodies to Factor VIII and Factor IX: ManagementSeminars in Thrombosis and Hemostasis, 2000
- THE DIAGNOSIS and MANAGEMENT OF FACTOR VIII and IX INHIBITORS: A GUIDELINE FROM THE UK HAEMOPHILIA CENTRE DOCTORS' ORGANIZATION (UKHCDO)British Journal of Haematology, 2000
- Factor IX Inhibitors and Anaphylaxis in Hemophilia BJournal of Pediatric Hematology/Oncology, 1997
- Immune tolerance induction in haemophiliacs with inhibitor to FVIII: high‐ or low‐dose programmeHaemophilia, 1996
- Immune Tolerance for the Treatment of Factor VIII Inhibitors ‐ Twenty Years' ‘Bonn Protocol’Vox Sanguinis, 1996
- The use of continuous infusion of factor concentrates in the treatment of hemophiliaAmerican Journal of Hematology, 1989
- Induction of Immune Tolerance in Patients with Hemophilia and Antibodies to Factor VIII by Combined Treatment with Intravenous IgG, Cyclophosphamide, and Factor VIIINew England Journal of Medicine, 1988
- The Management of Haemophiliacs who have Antibodies to Factor VIIIScandinavian Journal of Haematology, 1984